About

Qiagen offers testing solutions for infectious diseases – most notably TB, HIV, hepatitis, herpes and cytomegalovirus (CMV) – as well as oncology, and immune response modulation. In March 2020, Qiagen’s QIAstat-Dx Respiratory SARS-CoV-2 Panel, which is an RT-PCR test for detecting and differentiating nucleic acids from multiple respiratory viral and bacterial organisms, received an FDA EUA that allowed it to be used for diagnosing Covid-19.